Late-onset heart failure as a mechanism for adverse long-term outcome in diabetic patients undergoing revascularization (a 13-year report from the Lady Davis Carmel Medical Center Registry)

American Journal of Cardiology

Volumn 85, Issue 12, 2000, Pages 1420-1426

  Halon, David A ^a   Merdler, Amnon ^a   Flugelman, Moshe Y ^a   Rennert, Hedy S ^b   Weisz, Giora ^a   Shahla, Johnny ^a   Lewis, Basil S ^a  

^a Research Unit   (Israel)

^b CARMEL MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; DISEASE COURSE; FEMALE; FOLLOW UP; HEART FAILURE; HEART MUSCLE REVASCULARIZATION; HOSPITALIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY BYPASS; CORONARY DISEASE; DIABETES COMPLICATIONS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 0034659638     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(00)00788-8     Document Type: Article

References (30)

1. Rozenman Y., Sapoznikov D., Mosseri M., Gilon D., Lotan C., Nassar H., Weiss A.T., Hasin Y., Gotsman M.S. Long-term angiographic follow-up of coronary balloon angioplasty in patients with diabetes mellitus a clue to the explanation of the results of the BARI study . J Am Coll Cardiol. 30:1997;1420-1425.
2. Silva J.A., White C.J. Diabetes mellitus as a risk factor for development of vulnerable (unstable) coronary plaque a review of possible mechanisms . J Interven Cardiol. 11:1998;19-36.
3. Carrozza J.P. Jr, Kuntz R.E., Fishman R.F., Baim D.S. Restenosis after arterial injury caused by coronary stenting in patients with diabetes mellitus. Ann Intern Med. 118:1993;344-349.
4. St Claire D.A. Jr, King S.B. III. Effect of diabetes mellitus on outcome after percutaneous transluminal coronary angioplasty. Coron Artery Dis. 7:1996;744-752.
5. Levine G.N., Jacobs A.K., Keeler G.P., Whitlow P.L., Berdan L.G., Leya F., Topol E.J., Califf R.M. Impact of diabetes mellitus on percutaneous revascularization (CAVEAT-I). CAVEAT-I Investigators. Coronary Angioplasty Versus Excisional Atherectomy Trial. Am J Cardiol. 79:1997;748-755.
6. Kornowski R., Mintz G.S., Kent K.M., Pichard A.D., Satler L.F., Bucher T.A., Hong M.K., Popma J.J., Leon M.B. Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia. A serial intravascular ultrasound study. Circulation. 95:1997;1366-1369.
7. Van Belle E., Bauters C., Hubert E., Bodart J.C., Abolmaali K., Meurice T., McFadden E.P., Lablanche J.M., Bertrand M.E. Restenosis rates in diabetic patients a comparison of coronary stenting and balloon angioplasty in native coronary vessels . Circulation. 96:1997;1454-1460.
8. Fietsam R. Jr, Bassett J., Glover J.L. Complications of coronary artery surgery in diabetic patients. American Surgeon. 57:1991;551-557.
9. Shindler D.M., Kostis J.B., Yusuf S., Quinones M.A., Pitt B., Stewart D., Pinkett T., Ghali J.K., Wilson A.C. Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry. Am J Cardiol. 77:1996;1017-1020.
10. Solang L., Malmberg K., Ryden L. Diabetes mellitus and congestive heart failure. Further knowledge needed. Eur Heart J. 20:1999;789-795.
11. Halon D.A., Merdler A., Flugelman M.Y., Shifroni G., Khader N., Shiran A., Shahla J., Lewis B.S. Importance of diabetes mellitus and systemic hypertension rather than completeness of revascularization in determining long-term outcome after coronary balloon angioplasty (the LDCMC registry). Am J Cardiol. 82:1998;547-553.
12. Halon D.A., Flugelman M.Y., Merdler A., Rennert H., Shahla J., Lewis B.S. Long-term (10 year) outcome in patients with unstable angina pectoris treated by coronary balloon angioplasty. J Am Coll Cardiol. 32:1998;1603-1609.
13. Philbin E.F., Roerden J.B. Identifying patients at risk for recurrent hospital admission for heart failure. (abstr) J Am Coll Cardiol. 31:1998;305A.
14. Stone P.H., Muller J.E., Hartwell T., York B.J., Rutherford J.D., Parker C.B., Turi C.G., Strauss H.W., Willerson J.T., Robertson T. The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis . J Am Coll Cardiol. 14:1989;49-57.
15. Singer D.E., Moulton A.W., Nathan D.M. Diabetic myocardial infarction. Interaction of diabetes with other preinfarction risk factors. Diabetes. 38:1989;350-357.
16. Melchior T., Gadsboll P., Hildebrandt P., Kober L., Torp-Pedersen C. Clinical characteristics, left and right ventricular ejection fraction, and long-term prognosis in patients with non-insulin-dependent diabetes surviving an acute myocardial infarction. Diabet Med. 13:1996;450-456.
17. Woodfield S.L., Lundergan C.F., Reiner J.S., Greenhouse S.W., Thompson M.A., Rohrbeck S.C., Deychak Y., Simoons M.L., Califf R.M., Topol E.J., Ross A.M. Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction the GUSTO-I experience . J Am Coll Cardiol. 28:1996;1661-1669.
18. Judge K.W., Pawitan Y., Caldwell J., Gersh B.J., Kennedy J.W. Congestive heart failure symptoms in patients with preserved left ventricular systolic function analysis of the CASS registry . J Am Coll Cardiol. 18:1991;377-382.
19. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med. 335:1996;217-225.
20. Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease the Bypass Angioplasty Revascularization Investigation (BARI) . Circulation. 96:1997;1761-1769.
21. Ellis S.G., Narins C.R. Problem of angioplasty in diabetics. [editorial comment] Circulation. 96:1997;1707-1710.
22. Weintraub W.S., Stein B., Kosinski A., Douglas J.S., Ghazzal Z.M.B., Jones E.L., Morris D.C., Guyton R.A., Craver J.M., King S.B. III. Outcome of coronary bypass surgery versus coronary angioplasty in diabetic patients with multivessel coronary artery disease. J Am Coll Cardiol. 31:1998;10-19.
23. O'Keefe J.H., Blackstone E.H., Sergeant P., McCallister B.D. The optimal mode of coronary revascularization for diabetics. A risk-adjusted long-term study comparing coronary angioplasty and coronary bypass surgery. Eur Heart J. 19:1998;1696-1703.
24. Barsness G.W., Peterson E.D., Ohman E.M., Nelson C.L., DeLong E.R., Reves J.G., Smith P.K., Anderson R.D., Jones R.H., Mark D.B., Califf R.M. Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty. Circulation. 96:1997;2551-2556.
25. Lincoff A.M., Califf R.M., Moliterno D.J., Ellis S.G., Ducas J., Kramer J.H., Kleiman N.S., Cohen E.A., Booth J.E., Sapp S.K., Cabot C.F., Topol E.J. Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. N Engl J Med. 341:1999;319-327.
26. Pyorala K., Pedersen T.R., Kjekshus J., Faergeman O., Olsson A.G., Thorgeirsson G. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease a subgroup analysis of the Scandinavian Simvastatin Survival Study (4S) . Diabetes Care. 20:1997;614-620.
27. Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med. 342:2000;145-153.
28. Zuanetti G., Latini R., Maggioni A.P., Franzosi M.-G., Santoro L., Tognoni G. Effect of the ACE inhibitor lisinopril on mortality in diabetic patients with acute myocardial infarction data from the GISSI-3 study . Circulation. 96:1997;4239-4245.
29. Elezi S., Kastrati A., Pache J., Wehinger A., Hadamitzky M., Dirschinger J., Neumann F.-J., Schomig A. Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement. J Am Coll Cardiol. 32:1998;1866-1873.
30. Abizaid A., Kornowski R., Mintz G.S., Hong M.K., Abizaid A.S., Mehran R., Pichard A.D., Kent K.M., Satler L.F., Wu H., Popma J., Leon M.B. The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. J Am Coll Cardiol. 32:1998;584-589.